- Sections
- C - Chimie; métallurgie
- C07K - Peptides
- C07K 7/08 - Peptides linéaires ne contenant que des liaisons peptidiques normales ayant de 12 à 20 amino-acides
Détention brevets de la classe C07K 7/08
Brevets de cette classe: 6649
Historique des publications depuis 10 ans
506
|
530
|
512
|
516
|
573
|
582
|
536
|
527
|
438
|
120
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
Immatics Biotechnologies GmbH | 1144 |
255 |
The Regents of the University of California | 18943 |
107 |
Bicyclerd Limited | 130 |
70 |
Centre National de La Recherche Scientifique | 9632 |
69 |
Protagonist Therapeutics, Inc. | 124 |
54 |
Bicycletx Limited | 149 |
47 |
Caregen Co., Ltd. | 241 |
43 |
Bristol-myers Squibb Company | 5080 |
41 |
Toagosei Co., Ltd. | 894 |
40 |
GemVax & Kael Co., Ltd. | 84 |
38 |
The University of British Columbia | 1432 |
35 |
Bausch Health Ireland Limited | 751 |
35 |
Takeda Pharmaceutical Company Limited | 2961 |
33 |
Agency for Science, Technology and Research | 3512 |
32 |
Kagoshima University | 284 |
30 |
Seoul National University R&db Foundation | 2976 |
30 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
29 |
Oncotherapy Science, Inc. | 302 |
28 |
University of Pittsburgh - Of the Commonwealth System of Higher Education | 2912 |
28 |
The Trustees of the University of Pennsylvania | 4122 |
26 |
Autres propriétaires | 5579 |